After DEA floats telehealth prescribing rule, experts say it needs work

Why This Topic Matters

The proposed rule could change how telehealth practices manage controlled-substance prescribing, documentation, registration, and compliance. Understanding the policy discussion helps organizations assess operational impact and prepare comments or internal workflows.

Article Sections

1. Telehealth

   Introduces the DEA’s proposed telehealth prescribing rule and the broader policy context surrounding controlled-substance prescribing via telehealth.

2. Experts predict administrative burden, patient impact

   Summarizes stakeholder concerns about the proposal’s operational effects, including registration structure, documentation, monitoring requirements, and possible access implications.

3. Look for statements you can use

   Explains the public comment opportunity and notes the role of professional and advocacy organizations in preparing feedback on the proposal.

4. Resource

   Provides a reference link to the proposed rule and comment portal.